A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. - Wikidata - awgldk - TriplyDB

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

http://www.wikidata.org/entity/Q36365516

about

Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?Disordered regulation of coagulation and platelet activation in xenotransplantation.The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission.Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance.The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.Progress with retroviral gene vectors.Specificity and prevalence of natural bovine anti-alpha galactosyl (Galalpha1-6Glc or Galalpha1-6Gal) antibodies An approach to the control of disease transmission in pig-to-human xenotransplantation.No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells.Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells Structural and functional anatomy of the globular domain of complement protein C1q.Cell targeting in anti-cancer gene therapy A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes Plasmoviruses: nonviral/viral vectors for gene therapy.Barriers to Infection of Human Cells by Feline Leukemia Virus: Insights into Resistance to Zoonosis.Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses.Natural protection from zoonosis by alpha-gal epitopes on virus particles in xenotransmission.PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum.Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.Viral gene delivery.Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors.Human serum-resistant retroviral vector particles from galactosyl (alpha1-3) galactosyl containing nonprimate cell lines.Complement and anti-alpha-galactosyl natural antibody-mediated inactivation of murine retrovirus occurs in adult serum but not in umbilical cord serum.Generation of monoclonal antibodies against the Galβ1-4Gal epitope: a key tool in studies of species-specific glycans expressed in fish, amphibians and birds.Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.Infection and xenotransplantation. Developing strategies to minimize risk.Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.Distribution of retroviral vectors and vector producer cells using two routes of administration in rats.

P2860

Q28675345-219C7D74-FB3D-4F64-8849-963E1F922DB9 Q28729917-5A5652CC-8795-4614-A2D2-8DE96BA945E0 Q28755302-BA389B04-B9AD-4420-BD2A-93A3EDCD68E7 Q30248270-1D692D24-8DD1-4DCA-B898-184736B767BD Q33334538-95801E0F-E9D8-4B2B-AB13-B895EB7114EC Q33478403-BEA9D0D7-45AC-4588-B7C4-0EFF8D6B1662 Q33538414-D0067358-E261-4DF1-B9A9-D909AC55B5A8 Q33817487-34296D3B-783E-4753-9DEA-2EC24336B4BB Q33825579-891FBAC3-35E2-4433-A39F-BFC6BAC8B87A Q33920752-8FD0B213-D3DC-4C23-A33C-96F33989FB15 Q33998415-1AFCFA8F-2667-49BA-9473-17E3032373DC Q34015350-47D4FE85-4CAA-4381-9B73-9C6580EFE3A9 Q34188640-1D5F0376-3E5B-44F9-A462-48464FBC37F0 Q34331007-4C438BE1-9388-4BB5-B7C7-01B8BE2732E0 Q34597583-189273C0-A503-455D-BBB5-211C4993CBEE Q35131235-BC34E9C7-423C-43AC-9D98-9B0684DD3B39 Q35638775-675646DA-3357-4C8F-B276-C381D2480667 Q35896873-36D998DB-5807-4E0F-A0C4-F9309BC7ED4E Q36222776-31AA9828-28DC-4186-B6F0-30D6206FA384 Q37251604-29C0F4E9-4B8A-4E27-8FFC-1FBAB7E21E5A Q37631837-15380173-EA9C-44C6-8E48-15F000BBA69F Q37642870-6CCD2FA5-3494-4FBB-8F78-FD525369ADB2 Q37919109-411A5A70-22AD-4919-BA28-F56DAE3F9C6F Q38341233-E6B6136B-3CFF-4B1C-8CBF-F880419B594B Q39001370-1388C28F-FE5F-4913-8188-9F721F713F34 Q39580367-39DC8D44-E50A-4B5A-B791-CE0738053B96 Q39880641-25C54287-D1E6-45D5-8CDA-F0CB2DD18B92 Q40132922-9D6BF893-2FEF-4668-B11F-B9EF34811AEC Q40155038-F6D7FC0F-DF7C-40FC-8919-23FFF5E9A004 Q40674636-E2372DCB-B6DE-445B-91D5-95665A8876C3 Q40718975-E9045170-772B-4DA7-BB9B-6C1C16FD0597 Q40732042-9946A244-D6BF-4D5D-AD68-860013F2F2B3 Q40797068-F1648105-9EF8-4E31-9E95-13BECDAAFF43 Q40931998-C303375F-11BB-4A57-9633-1196C963B463 Q40952196-05412BEA-5224-4716-B50E-8937F98CD7CE Q42716094-E8A2CF92-1D93-4738-BA5A-3A651D15994C Q44368424-B58341D2-89BB-4B7E-B952-DE15DF8029E1 Q44825658-2D7D440D-4D19-4425-B819-40102A685CF4 Q45861534-270691D2-F1AE-47BD-A9D5-1D66FB814A8C Q45861885-EF25910D-2DBE-462A-A1C8-8AEB866BED95

P2860

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

http://www.wikidata.org/entity/Q36365516

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@ast

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@en

type

label

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@ast

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@en

prefLabel

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@ast

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@en

P1433

Q36365516-325F8470-74BB-4E0C-BB06-13996F211E81

P1476

Q36365516-3CA6E0AA-419B-4E9D-B1B9-82EAFD42C788

P2093

Q36365516-263A163D-743E-4960-80D8-D53A8B4613B1

Q36365516-49052060-F505-4BEA-8777-7731AA040DED

Q36365516-5A9E387F-893D-4248-9C1C-C7BA69BC92A7

Q36365516-5AAC3B2B-8DD9-4AED-89AB-C8407C8A785D

Q36365516-74FD921A-A542-432C-AF99-7056B55BEA36

Q36365516-A9E53F53-2B5E-45B1-BCE1-2048DAC2DAD9

Q36365516-E7E645EA-0F7D-428A-943E-ACA4DCECFCC2

Q36365516-E8D3EFAC-6657-4A1F-A96B-E6730D4A2110

P2860

Q36365516-0C84AD41-EE84-44C3-B174-187F066DF528

Q36365516-0F3034D8-5EB2-4B95-9266-9B1A53F04663

Q36365516-124866DF-B33F-4D7D-ABFF-A53B07CE4BD7

Q36365516-1321398D-1592-4025-A765-73763284DADB

Q36365516-1A8A3536-191D-4B4C-A902-6CC58C520178

Q36365516-1D9B0915-FEF6-4997-890F-1BDB7AD5D962

Q36365516-1F4C1BC3-AA80-448F-BBBE-961BA3F19745

Q36365516-21FFFA11-A31C-495E-8821-31B988B4CAD2

Q36365516-246EAAAB-CCDE-40F7-ACAB-05D1D4473195

Q36365516-33A36375-2CD2-4714-8C8D-D1E6DDBA7DE4

P304

Q36365516-3516A193-4841-4593-9A07-61B7F4BBA574

P31

Q36365516-ABADC76B-D95C-411E-A70E-DF1D6FB0D0F7

P356

Q36365516-7FBCF6D1-7321-4CD9-A0F2-D6F47865648C

P407

Q36365516-6EF926E2-6BCB-48F1-853A-F6DDBF9B0489

P433

Q36365516-EFB96854-F919-4F78-B980-BB068BADA843

P478

Q36365516-C7F1BEC1-8081-4E24-A678-474EEED6BB51

P577

Q36365516-8E3D11EE-E97B-4696-AAC4-EA12B74797A5

P5875

Q36365516-9336D7F0-1BE6-416C-AE9D-B5BDC5A3FEF7

P698

Q36365516-21B2656F-0A53-4628-8AF8-C7BE402385ED

P921

Q36365516-0349C072-CB2A-400C-AF91-9B98F4DDBD0B

Q36365516-B82CC0CA-95C4-4511-87ED-FC4B2285F80E

P932

Q36365516-287AAD58-CCC6-474E-8A76-E36E1BE4D186

P356

P1433

Journal of Experimental Medicine

P1476

A novel mechanism of retroviru ...... a-galactosyl natural antibody.

@en

P2093

Birks CW

http://www.w3.org/2001/XMLSchema#string

Fodor WL

http://www.w3.org/2001/XMLSchema#string

Rollins SA

http://www.w3.org/2001/XMLSchema#string

Rother RP

http://www.w3.org/2001/XMLSchema#string

Sandrin MS

http://www.w3.org/2001/XMLSchema#string

Setter E

http://www.w3.org/2001/XMLSchema#string

Springhorn JP

http://www.w3.org/2001/XMLSchema#string

Squinto SP

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen

INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS

Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies

Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora

Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes

Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys

Improved retroviral vectors for gene transfer and expression.

Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA.

P304

1345-1355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.182.5.1345

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277422277

http://www.w3.org/2001/XMLSchema#string

P698

7595205

http://www.w3.org/2001/XMLSchema#string

P921

alpha-D-galactosyl-(1->3)-D-galactose

P932

2192220

http://www.w3.org/2001/XMLSchema#string